• Join
  • Login
  • Contact

Search abstracts / presentations

Simultaneous determination of erlotinib and its major metabolites in human plasma using an isocratic liquid chromatography tandem mass spectrometry

  • In: Posters G - Pharmacokinetics (PK), Pharmacodynamics (PD) and Systems Pharmacology
  • At: PSWC, Melbourne (Australia) (2014)
  • Type: Poster
  • Poster code: PG-017
  • By: ISHIDA, Takuya (Hamamatsu University School of Medicine, Hospital Pharmacy, Hamamatsu, Japan)
  • Co-author(s): Naito, Takafumi (Hamamatsu University School of Medicine, Hamamatsu, Japan)
    Suda, Takafumi (Hamamatsu University School of Medicine, Hamamatsu, Japan)
    Kawakami, Junichi (Hamamatsu University School of Medicine, Hamamatsu, Japan)
  • Abstract:

    Background: Erlotinib is a selective inhibitor of the epidermal growth factor receptor tyrosine kinase. The relations between the concentrations of its active metabolites, OSI-413 and OSI-420, and clinical response or adverse effect remain unclear. In earlier methods, the concentrations of these metabolites were determined as a total amount.
    Aims: ..

  • The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 28 September 2023

FIP Congresses